One of such gain-of-function activities of mutant p53 is to inhibit ATM [48], which allows cancer cells to abrogate the TRF2-ATM-p53 feedback regulation in a more active manner than simply losing or inactivating wild-type p53. This evidence concerns the gene TERF2 and cancer.